论文部分内容阅读
由于肺癌早期诊断的困难，约８６％的病人一经确诊即为Ⅲ期～Ⅳ期。失去手术机会，只能采用放疗、化疗等，所以，寻求疗效最好的化疗方案是提高肺癌生存率的关键。我们自１９９８年５月—１９９９年７月观察以诺维本为主的联合化疗治疗肺癌的近期疗效，取得了较好疗效，现报告
Due to the difficulty of early diagnosis of lung cancer, about 86% of patients are diagnosed as stage III to IV. Without surgery, only radiotherapy and chemotherapy can be used. Therefore, seeking the best chemotherapy is the key to improving the survival rate of lung cancer. From May 1998 to July 1999, we observed the short-term efficacy of Novartis-based combination chemotherapy in the treatment of lung cancer and achieved good results.